latest news releases from the newsroom
Prosci Announces New Managers' Coaching Course
LOVELAND, Colo., July 24, 2008 (PRIME NEWSWIRE) -- Prosci, the global leader in research and development of leadership tools for managing the people side of change, announced its 2008 Managers' 1-Day Coaching Course. This course is designed to help managers effectively lead their employees through change.
MetroCorp Bancshares Inc.
MetroCorp Bancshares, Inc. Announces Net Income of $2.3 Million, or $0.21 Per Diluted Share, in Second Quarter 2008, and Total Assets of $1.58 Billion
HOUSTON, July 24, 2008 (PRIME NEWSWIRE) -- MetroCorp Bancshares, Inc. (Nasdaq:MCBI), a Texas corporation, which provides community banking services through its subsidiaries, MetroBank, N.A., serving Texas, and Metro United Bank, serving California, today announced the results for the second quarter of 2008.
First State Financial Corporation
First State Financial Corporation Announces Second Quarter 2008 Results
SARASOTA, Fla., July 24, 2008 (PRIME NEWSWIRE) -- First State Financial Corporation (Nasdaq:FSTF) today reported a second quarter 2008 net loss of $2.2 million, or a loss of $0.38 per diluted share, as compared to net income of $797 thousand, or $0.14 per diluted share for the same period in 2007. First State's second quarter 2008 net loss was primarily attributable to a $3.7 million provision for loan losses and a decrease in net interest income, partially offset by a tax benefit as a result of the second quarter 2008 loss.
WSFS Financial Corporation
WSFS Reports EPS of $1.07 for the 2nd Quarter 2008
WILMINGTON, Del., July 24, 2008 (PRIME NEWSWIRE) -- WSFS Financial Corporation (Nasdaq:WSFS), the parent company of Wilmington Savings Fund Society, FSB, reported quarterly diluted earnings per share of $1.07, or net income of $6.7 million, compared to $1.11, or $7.2 million in the second quarter of 2007. Net income for the first six months of 2008 was $13.9 million, or $2.22 per diluted share, compared to $15.0 million, or $2.26 in 2007.
XOMA Begins Phase 2a Clinical Trial to Evaluate XOMA 629 Topical Gel as a Treatment for the Common Skin Disease, Impetigo
BERKELEY, Calif., July 24, 2008 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, today announced the start of its Phase 2a clinical trial to evaluate XOMA 629, a topical gel formulation of an antimicrobial drug candidate, as a treatment for impetigo. Impetigo is a superficial skin infection caused by bacteria, and is more common in children and young adults. It is estimated to affect one million people in the U.S. annually.
Interphase Announces Second Quarter 2008 Financial Results
PLANO, Texas, July 24, 2008 (PRIME NEWSWIRE) -- Interphase Corporation (Nasdaq:INPH), a leading international supplier of next-generation networking technologies, today reported financial results for its second quarter ended June 30, 2008.